NYSE: ABBV
Abbvie Inc Stock Ownership - Who owns Abbvie?

Insider buying vs selling

Have Abbvie Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Scott T. ReentsEVP CHIEF FINANCIAL OFFICER2025-03-1417,644$212.34
$3.75MSell
Richard A. GonzalezDirector2025-03-036,168$210.53
$1.30MSell
Perry C. SiatisEVP GC AND SECRETARY2025-03-037,315$149.62
$1.09MBuy
Perry C. SiatisEVP GC AND SECRETARY2025-03-032,918$144.54
$421.77kBuy
Timothy J. RichmondEVP CHIEF HR OFFICER2025-03-03600$211.32
$126.79kSell
Perry C. SiatisEVP GC AND SECRETARY2025-03-0318,008$210.00
$3.78MSell
Perry C. SiatisEVP GC AND SECRETARY2025-03-037,775$175.28
$1.36MBuy
Timothy J. RichmondEVP CHIEF HR OFFICER2025-03-035,677$209.80
$1.19MSell
Timothy J. RichmondEVP CHIEF HR OFFICER2025-03-0314,973$210.66
$3.15MSell
Roopal ThakkarEVP RD and CSO2025-02-284,678$205.02
$959.08kSell

1 of 5

ABBV insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ABBV insiders and whales buy or sell their stock.

ABBV Shareholders

What type of owners hold Abbvie Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc9.80%173,072,078$36.35BInstitution
Blackrock Inc8.05%142,035,565$29.83BInstitution
State Street Corp4.51%79,621,487$16.72BInstitution
Jpmorgan Chase Co2.93%51,762,491$10.87BInstitution
Morgan Stanley2.25%39,689,164$8.34BInstitution
Geode Capital Management LLC2.10%37,144,933$7.80BInstitution
Capital Research Global Investors1.93%33,983,707$7.14BInstitution
Capital International Investors1.62%28,533,488$5.99BInstitution
Charles Schwab Investment Management Inc1.55%27,436,133$5.76BInstitution
Bank Of America Corp1.43%25,323,965$5.32BInstitution

1 of 3

ABBV vs General Drug Manufacturer Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ABBV72.11%0.15%Net SellingNet Selling
JNJ71.75%0.19%Net SellingNet Selling
MRK77.92%0.21%Net BuyingNet Buying
AZN33.11%0.00%
NVS6.61%0.00%

Abbvie Stock Ownership FAQ

Who owns Abbvie?

Abbvie (NYSE: ABBV) is owned by 72.11% institutional shareholders, 0.15% Abbvie insiders, and 27.74% retail investors. Vanguard Group Inc is the largest individual Abbvie shareholder, owning 173.07M shares representing 9.80% of the company. Vanguard Group Inc's Abbvie shares are currently valued at $36.35B.

If you're new to stock investing, here's how to buy Abbvie stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.